Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial
- 29 February 2012
- journal article
- research article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 206 (2), 129.e1-129.e8
- https://doi.org/10.1016/j.ajog.2011.09.021
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraceptionAmerican Journal of Obstetrics and Gynecology, 2010
- Endometrial effects of intrauterine levonorgestrelContraception, 2007
- Treatment of vaginal bleeding irregularities induced by progestin only contraceptivesPublished by Wiley ,2007
- Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trialsContraception, 2007
- Effect of mefenamic acid on controlling irregular uterine bleeding in DMPA usersContraception, 2004
- Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine systemContraception, 1996
- Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: A randomized comparative trialContraception, 1994
- A Latin American Experience with Levonorgestrel IUDAnnals of Medicine, 1993
- Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-TContraception, 1992
- Clinical assessment of treatments for prolonged bleeding in users of norplantR implantsContraception, 1990